Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,388 | 15,055 | 16,130 | 11,874 | 6,029 |
| Marketable Securities | 257 | 294 | 1,146 | 287 | N/A |
| Receivables | 4,522 | 6,014 | 5,496 | 5,725 | 164 |
| Inventories | 14,671 | 16,382 | 17,574 | 12,979 | N/A |
| Other current assets | 1,419 | 1,015 | 1,481 | 934 | 196 |
| TOTAL | $28,258 | $38,760 | $41,827 | $31,799 | $6,389 |
| Non-Current Assets | |||||
| PPE Net | 33,208 | 30,192 | 24,858 | 21,276 | 721 |
| Intangibles | 55,137 | 54,578 | 55,079 | 57,761 | 1,166 |
| Other Non-Current Assets | 367 | 318 | 239 | 240 | 327 |
| TOTAL | $88,713 | $85,088 | $80,176 | $79,277 | $2,214 |
| Total Assets | $116,971 | $123,848 | $122,003 | $111,076 | $8,603 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 2,201 | 2,198 | N/A |
| Accounts payable and accrued liabilities | 7,622 | 9,350 | 8,907 | 8,264 | 342 |
| Accrued Expenses | 4,709 | 4,993 | 3,201 | 1,069 | 1,336 |
| Other current liabilities | 1,694 | 1,433 | 4,277 | 2,040 | 199 |
| TOTAL | $20,570 | $26,678 | $31,168 | $25,224 | $2,680 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 7,146 | 6,448 | 19,865 | 21,224 | 7,737 |
| TOTAL | $12,687 | $12,379 | $25,574 | $28,020 | $7,737 |
| Total Liabilities | $33,257 | $39,057 | $56,742 | $53,244 | $10,417 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 38 | 38 | 35 | 29 | 24 |
| Common Shares | 58 | 57 | 44 | 37 | 9 |
| Retained earnings | -88,979 | -81,840 | -76,385 | -71,777 | -54,428 |
| Other shareholders' equity | 39,660 | 37,088 | 35,273 | 33,863 | -8 |
| TOTAL | $83,713 | $84,791 | $65,261 | $57,832 | $-1,814 |
| Total Liabilities And Equity | $116,971 | $123,848 | $122,003 | $111,076 | $8,603 |